Published Date: 08 Mar 2023
A study by Concordia undergraduate students suggests that a simple vitamin can cure a rare but life-threatening disease.
Read Full NewsThird molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.
Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.
The World Health Organization on Thursday declared the hantavirus outbreak linked to a cruise ship over after the last identified contact of an exposed person completed...
New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said a migratory seabird found near a coastal town returned a positive...
The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.
New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.
A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.
1.
Gotistobart Response Rate Bests Chemo in Pretreated NSCLC
2.
healthy despite having advanced cancer.
3.
Home Screening Appeals to Women Facing Healthcare Barriers
4.
FDA Says First 'Real-Time' Clinical Trial Is Underway
5.
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP
1.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
2.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
3.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
4.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
5.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
5.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation